Bundamedik Tbk vs Citra Borneo Utama Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Citra Borneo Utama Tbk. trades at Rp795 (market cap 2.47T, 58.6K 24h volume). The key difference: Citra Borneo Utama Tbk. is the larger of the two by market cap, and Bundamedik Tbk is more actively traded (536.7K versus 58.6K). Which is the better fit depends on your goals.
| BMHS | CBUT | |
|---|---|---|
Market Cap | 1.51T | 2.47T |
Volume | 536.7K | 58.6K |
Lot | 5.37K | 586 |
Turnover | 93.41M | 46.6M |
Average Price | 174.05 | 795.15 |
Value | 93.41M | 46.6M |
Indicative Equilibrium Price | 176 | 795 |
Indicative Equilibrium Volume | 100 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →